Medications

Maker of Wegovy limits supply of obesity drug in US

Danish drugmaker Novo Nordisk said Thursday it will limit distribution of its low-dose versions of the wildly popular weight-loss drug Wegovy, to ensure that people already taking the drug will have enough supply.

Addiction

Xylazine: The new overdose crisis

When she entered Cooper University Hospital's outpatient clinic in Camden, New Jersey, in October 2021, Ashley (last name withheld due to privacy concerns) could barely walk.

Genetics

Chromosomal testing expands options for exploring causes of SIDS

A genetic test known as chromosomal microarray analysis (CMA) could help identify the cause of sudden infant death syndrome (SIDS) or its counterpart in older children, known as sudden unexplained death in childhood (SUDC), ...

page 2 from 9